Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lonza Group AG

LONN.S ✓ COMPLIANT ☆ Track — members

Europe · Healthcare · Biotechnology & Medical Research ·

Switzerland Large Cap Analyst: BUY

Last Close

$650.90

▼ -0.71%

Market Cap $45.91B · Vol 125.39K

Key Metrics

P/E Ratio

35.36

FWD: 27.79

Market Cap

$45.91B

Large Cap

Div Yield

0.94%

Dividend with no set frequency

EPS Growth

+15.54%

YoY

RSI (14)

16.07

Momentum

Beta

1.23

vs Market

52W High

$732.51

14.61% below

52W Low

$557.04

12.57% above

Volume

125.39K

Avg 115.38K

P/B

4.75

Price-to-book

ROE

11.40%

Return on equity

Free Float

99.91%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Lonza Group AG (LONN.S) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LONN.S pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.35%

-7.68%

+7.97%

+8.50%

YTD

-1.23%

-4.87%

+19.67%

-30.78%

Financials & Valuation

TTM · Annual

Total Revenue	$8.24B
Net Income	$1.15B
Revenue Growth (YoY)	+11.21%
Gross Margin	54.25%
Operating Margin	41.85%
Net Profit Margin	13.92%
ROE	11.40%
ROA · ROIC	5.85% · -1.05%

P/E Ratio	35.36
Forward P/E (FY1)	27.79
PEG Ratio	0.77
P/S	5.77
P/B	4.75
P/FCF	N/A
EPS Growth	+15.54%
Outstanding Shares	70.23M

Technical Indicators

50-Day SMA	$698.11
200-Day SMA	$649.37
RSI (14)	16.07
Beta	1.23
52-Week High	$732.51
52-Week Low	$557.04

Volume Today	125.39K
Avg Daily Volume (30D)	115.38K
Relative Volume	1.09x
Volatility (10D)	18.70
Volatility (30D)	19.59
Free Float	99.91%

Analyst Consensus

BUY

Current Price $650.90

Mean Target $848.48

52W Low$557.04 52W High$732.51

Current

Target

$557.04 $732.51

Current Analyst target

+30.35% upside potential · 25 analysts

Identifiers

ExchangeEurope

FIGIBBG001SDFZX8

ISINCH0013841017

CountrySwitzerland

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateJan 26, 2027

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ONC BeOne Medicines AG +1.38% 068270.KS Celltrion, Inc. -1.44% ABVX Abivax SA +2.32% ABVX.PA Abivax SA +1.00% MEDP Medpace Holdings, Inc. +0.75%

Company Profile

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.